Page last updated: 2024-08-24

lisofylline and Autoimmune Demyelinating Diseases, Central Nervous System

lisofylline has been researched along with Autoimmune Demyelinating Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bright, JJ; Sriram, S1

Reviews

1 review(s) available for lisofylline and Autoimmune Demyelinating Diseases, Central Nervous System

ArticleYear
Immunotherapy of inflammatory demyelinating diseases of the central nervous system.
    Immunologic research, 2001, Volume: 23, Issue:2-3

    Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Chlamydia Infections; Chlamydophila pneumoniae; Cytokines; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Glatiramer Acetate; Humans; Immunotherapy; Inflammation; Interleukin-12; Mice; Multiple Sclerosis; Pentoxifylline; Peptides; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction; Transforming Growth Factor beta

2001